These participations seek to strengthen their relationships with investors and the global pharmaceutical community, and to showcase their latest scientific breakthroughs.
The first date on the calendar is the MedCap Forum 2025, which will be held from May 27th to the 29th at the iconic Palacio de la Bolsa in Madrid. During this event, Oryzon will hold strategic meetings with national and international investors, consolidating its position in the financial market.
The company will then cross the Atlantic to attend the BIO International Convention 2025This prestigious meeting of the biotechnology industry will take place from June 16 to 19 at the Boston Convention & Exhibition Center in Boston, USAWithin this framework, Oryzon will meet with representatives of pharmaceutical companies and international investors, exploring synergies and collaboration opportunities.
Finally, Oryzon has been invited to present at the conference Discovery and Development Europe 2025Organized by Oxford Global, the event will take place from June 23-24 at the Congress Center Basel in Basel, Switzerland. Dr. Tamara Maes, a key figure in Oryzon research, will give a presentation entitled “LSD1 Inhibition: A Novel Therapeutic Strategy for Genetically Based Neurodevelopmental Syndromes,” highlighting the company’s advances in this promising field of epigenetics.
Participation in these forums underscores Oryzon's commitment to innovation and its strategy of expansion and visibility in the global biopharmaceutical landscape.
Any questions about this news?
Talk to Coexia, the AI of the foreign trade
